Home > Quotes > BTT > Company News

BlackRock Municipal Target Term Trust Inc. (The) News Headlines

BTT 
$22.78
*  
0.03
  negative  
0.13%
Get BTT Alerts
*Delayed - data as of May 17, 2013 
Exchange: NYSE

Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Thoratec Misses Earnings and Rev Est - Analyst Blog
5/6/2013 9:26:08 AM - Zacks.com

What Detroit And The Stockton Bankruptcy Mean For Bonds
4/3/2013 2:41:00 PM - Seeking Alpha

Thoratec Reveals Human Use of PHP - Analyst Blog
3/20/2013 9:48:11 AM - Zacks.com

BlackRock Municipal Target Term Trust Inc. (BTT) Ex-Dividend Date Scheduled for March 13, 2013
3/11/2013 9:00:04 AM - NASDAQ.com News

BlackRock Municipal Target Term Trust Inc. (BTT) Ex-Dividend Date Scheduled for February 13, 2013
2/11/2013 10:00:04 AM - NASDAQ.com News

Thoratec Beats, Posts Loss - Analyst Blog
2/6/2013 10:00:01 AM - Zacks.com

Thoratec Downgraded to Neutral - Analyst Blog
1/15/2013 5:00:01 PM - Zacks.com

BlackRock Municipal Target Term Trust Inc. (BTT) Ex-Dividend Date Scheduled for January 11, 2013
1/9/2013 10:00:03 AM - NASDAQ.com News

Thoratec Corp. - Momentum
12/14/2012 1:00:01 AM - Zacks.com

Thoratec Soars to 52-Week High - Analyst Blog
12/12/2012 6:35:01 PM - Zacks.com

Thoratec Wins Approval in Japan - Analyst Blog
12/12/2012 12:40:01 PM - Zacks.com

BlackRock Municipal Target Term Trust Inc. (BTT) Ex-Dividend Date Scheduled for December 12, 2012
12/10/2012 10:00:04 AM - NASDAQ.com News

Thoratec Retained at Outperform - Analyst Blog
12/6/2012 12:50:01 PM - Zacks.com

Thoratec Authorizes New Repurchase - Analyst Blog
11/27/2012 12:30:01 PM - Zacks.com

Much Awaited FDA Nod for HeartWare - Analyst Blog
11/21/2012 1:00:01 PM - Zacks.com

Thoratec Achieves 52-Week High - Analyst Blog
11/5/2012 6:10:01 PM - Zacks.com

Thoratec Beats with Ease; Ups View - Analyst Blog
11/2/2012 12:28:06 PM - Zacks.com

Thoratec Upgraded to Outperform - Analyst Blog
10/11/2012 11:50:25 AM - Zacks.com

Thoratec: A Strong Buy - Analyst Blog
10/4/2012 5:05:01 PM - Zacks.com